| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 20/Dec/1993 | 31/Dec/1997 | Canada | | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Research And Development In The Life Sciences
| The Company is involved in the development of products derived from cellular stress response technology and sells products on the technology to researchers worldwide. The Company is also developing technology and products to treat cancer and prevent certain infectious diseases.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *SSB | *Stressgen Biotechnologies Corporation | TSE | DELIST |
| *SSB | *Stressgen Biotechnologies Corporation | VSE | DELIST |
|
|
| Name History | From | To |
| *StressGen Biotechnologies Corp. | 6/Dec/1993 | 31/Dec/1997 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Fall 1997 CFR | Not Received |
|
|
|
|
|
